Connor, Clark & Lunn Investment Management (CC&L)’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,300
| Closed | -$245K | – | 1570 |
|
|
2024
Q1 | $245K | Buy |
+2,300
| New | +$245K | ﹤0.01% | 1338 |
|
|
2022
Q2 | – | Sell |
-8,188
| Closed | -$1.41M | – | 1144 |
|
|
2022
Q1 | $1.41M | Sell |
8,188
-92,153
| -92% | -$15.9M | 0.01% | 589 |
|
|
2021
Q4 | $25.5M | Sell |
100,341
-68,562
| -41% | -$17.4M | 0.12% | 142 |
|
|
2021
Q3 | $65M | Sell |
168,903
-69,255
| -29% | -$26.7M | 0.34% | 66 |
|
|
2021
Q2 | $56M | Sell |
238,158
-102,939
| -30% | -$24.2M | 0.28% | 73 |
|
|
2021
Q1 | $44.7M | Buy |
341,097
+256,641
| +304% | +$33.6M | 0.25% | 87 |
|
|
2020
Q4 | $8.82M | Buy |
84,456
+21,048
| +33% | +$2.2M | 0.05% | 242 |
|
|
2020
Q3 | $4.49M | Buy |
63,408
+24,801
| +64% | +$1.75M | 0.03% | 329 |
|
|
2020
Q2 | $2.48M | Buy |
+38,607
| New | +$2.48M | 0.02% | 415 |
|